Solomon, A., Tennakoon, S., Leeansyah, E., Arribas, J., Hill, A., Van Delft, Y., . . . Lewin, S. R. (2014). No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogues in the MONET Trial. PLoS ONE, 9(11), 1. https://doi.org/10.1371/journal.pone.0109718
Chicago Style (17th ed.) CitationSolomon, Ajantha, Surekha Tennakoon, Edwin Leeansyah, Jose Arribas, Andrew Hill, Yvon Van Delft, Christiane Moecklinghoff, and Sharon R. Lewin. "No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients After Three Years of Darunavir/Ritonavir with and Without Nucleoside Analogues in the MONET Trial." PLoS ONE 9, no. 11 (2014): 1. https://doi.org/10.1371/journal.pone.0109718.
MLA (9th ed.) CitationSolomon, Ajantha, et al. "No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients After Three Years of Darunavir/Ritonavir with and Without Nucleoside Analogues in the MONET Trial." PLoS ONE, vol. 9, no. 11, 2014, p. 1, https://doi.org/10.1371/journal.pone.0109718.